Daily Practice Treatment and Influence of Visanne on the Patient Assessment of Quality of Life (DIVA)
Status
Conditions
Treatments
Details and patient eligibility
About
The study aims to collect data on the influence of a treatment with Visanne (Dienogest 2mg/d) on the Endometriosis related quality of life. These data will be collected using a special patient questionnaire (Endometriosis Health Profile 5, EHP-5). The study will also be used to describe the basic disease status and demographic characteristics of patients searching treatment by a gynecologist because of their endometriosis. In addition, the study will give insight into the typical diagnostic measures the physicians in different countries are using in the field of endometriosis.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Female patients older than 18 years of age
- Clinical or laparoscopic diagnosis of endometriosis
- Having endometriosis related pain as leading symptom
- Decision taken by physician to prescribe Visanne
- Signed Informed Consent Form
Exclusion criteria
- Contraindications listed in the local summary of product characteristics (SPC) have to be considered.
Trial design
3,006 participants in 1 patient group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal